Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS ANNOUNCES GRADUATION TO TSX

28 February 2017

Quebec City, Quebec, February 28, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that it has received final approval for the listing of the Corporation’s common shares (the “Common Shares”) on the Toronto Stock Exchange (“TSX”). The Common Shares will commence trading on the TSX effective as of the…

Read more

OPSENS REPORTS Q1 2017 RESULTS – FOCUSED EXECUTION LEADS TO RECORD QUARTERLY REVENUES

26 January 2017

Quebec City, Quebec, January 26, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) today reported its results for the first quarter ended November 30, 2016. Highlights Fractional Flow Reserve (“FFR”) revenues were $2,743,000 compared with $893,000 in the same quarter last year, an increase of $1,850,000 or 207%; Consolidated revenues for Q1 2017…

Read more

OPSENS INC. COMPLETES A $14.95 MILLION EQUITY FINANCING BY WAY OF PROSPECTUS

8 December 2016

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OPSENS INC. COMPLETES A $14.95 MILLION EQUITY FINANCING BY WAY OF PROSPECTUS Quebec City, Quebec, December 8, 2016 – Opsens Inc. (“Opsens” or the “Corporation”) (TSXV: OPS) (OTCQX: OPSSF) is pleased to announce that it has closed its previously announced short form…

Read more

OPSENS ANNOUNCES UPSIZE TO AND PROVIDES ADDITIONAL DETAILS REGARDING ITS PROPOSED EQUITY FINANCING

23 November 2016

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OPSENS INC. ANNOUNCES UPSIZE TO AND provides additional details regarding its proposed equity financing Quebec City, Quebec, November 23, 2016 – Opsens Inc. (“Opsens” or the “Corporation”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that it has amended the terms of its…

Read more

Opsens Announces Equity Financing

23 November 2016

      NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Opsens Announces Equity Financing Quebec City, Quebec, November 22, 2016 – Opsens Inc. (“Opsens”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce that it has filed a preliminary short form prospectus in connection with a proposed marketed offering of common…

Read more

OPSENS REPORTS RESULTS FOR 2016 – RECORD TOTAL REVENUES DRIVEN BY TENFOLD INCREASE IN FFR SALES

16 November 2016

Quebec City, Quebec, November 16, 2016 – Opsens Inc. (“Opsens”) (TSXV:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2016. Highlights The OptoWire II, Opsens’ guidewire to measure Fractional Flow Reserve (“FFR”) has been authorized for sale in the U.S., Europe, Japan and Canada; FFR product sales FFR revenues were $2.1 million…

Read more

OPSENS RECEIVES 510(K) CLEARANCE FOR THE OPTOMONITOR II PROVIDING EXTENDED INDICATION

26 September 2016

OPSENS RECEIVES 510(K) CLEARANCE FOR THE OPTOMONITOR II PROVIDING EXTENDED INDICATION Quebec City, Quebec, September 26, 2016 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) announces 510(k) clearance from the U.S. Food and Drug Administration (“FDA“) for the OptoMonitor II, a new multimodality monitor combining the ability to measure Fractional Flow Reserve (“FFR”) along…

Read more

OPSENS APPOINTS PAT MACKIN TO ITS BOARD OF DIRECTORS

7 September 2016

Quebec City, Quebec, September 7, 2016 – Opsens Inc. (“Opsens”) (TSXV:OPS) (OTCQX:OPSSF) is pleased to announce the appointment of Mr Pat Mackin as a Director of the Company. “We are delighted to see Pat, a renowned leader in the medical device industry, join us. His expertise as head of leading companies in the cardiovascular space…

Read more

CIRCULATION JOURNAL HIGHLIGHTS OPTOWIRE PERFORMANCE

31 August 2016

CIRCULATION JOURNAL HIGHLIGHTS OPTOWIRE PERFORMANCE Quebec City, Quebec, August 15, 2016 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF)  announced today that OptoWire’s performance was highlighted in the Circulation Journal, the Official Journal of the Japanese Circulation Society. The article, written jointly by Dr. Nico HJ Pijls and Dr. Bernard de Bruyne is called…

Read more

OPSENS Q3 RESULTS – SALES OF $2,125,000, UP 156% YEAR-OVER-YEAR

5 July 2016

OPSENS ANNOUNCES FISCAL 2016 THIRD QUARTER RESULTS – SALES OF $2,125,000, UP 156% YEAR-OVER-YEAR Quebec City, Quebec, July 5, 2016 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) today released the results of its third quarter ended May 31, 2016. Highlights for the quarter and the last weeks Move into the new plant completed;…

Read more